Skip to main content
SpringerLink
Log in

Do inhaled corticosteroids stunt the growth of children?

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Earl T. The growing debate over corticosteroids in paediatric patients. Reactions 1999 May 1; 749: 3–4

    Article  Google Scholar 

  2. The safety of inhaled and nasal corticosteroids. Curr Probl Pharmacovigilance 1998 May; 24: 8

    Google Scholar 

  3. Wagener JS, Wojtczak HA. Inhaled steroids in children: risks versus rewards. J Pediatr 1998 Mar; 132: 381–3

    Article  PubMed  CAS  Google Scholar 

  4. Brook CGD. Short stature never killed anybody. J Pediatr 1998; 133: 591–2

    Article  PubMed  CAS  Google Scholar 

  5. Prompt control of asthma essential: the emphasis from the new US and UK guidelines. Drug Ther Perspect 1997 Apr 28; 9(8): 6–8

    Google Scholar 

  6. Juniper EF, Kline PA, Vanzieleghem MA, et al. Effect of long-term treatment with an inhaled corticosteroid (Budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990; 142: 832–6

    PubMed  CAS  Google Scholar 

  7. Ault A. Steroids need stricter paediatric growth warnings. Lancet 1998 Aug 8; 352: 461

    Article  Google Scholar 

  8. Food and Drug Administration. FDA requires new pediatric labeling for inhaled, intranasal corticosteroids. Media release 1998 Nov 9 [2 pages]

    Google Scholar 

  9. Doull IJM, Campbell MJ, Holgate ST. Duration of growth suppressive effects of regular inhaled corticosteroids. Arch Dis Child 1998 Feb; 78: 172–3

    Article  PubMed  CAS  Google Scholar 

  10. Covar R, Leung DYM, Chan MTS, et al. Risk factors associated with glucocorticoid (GC) side effects in adolescents with severe asthma — revisited [abstract]. J Allergy Clin Immunol 1999 Jan; 103 Pt 2: S61

    Google Scholar 

  11. Skoner DP, Welch M, Tinkleman D, et al. Inhaled corticosteroid-induced growth retardation in asthmatic children in a ‘Real World’ setting [abstract]. J Allergy Clin Immunol 1999 Jan; 103 Pt 2: S61

    Google Scholar 

  12. Chay OM, Goh A, Lim WH. Effects of inhaled corticosteroid on bone turnover in children with bronchial asthma. Respirology 1999 Jan; 4: 63–7

    Article  PubMed  CAS  Google Scholar 

  13. DeMasi JM. Steroid use and bone metabolism in pediatric asthmatics [abstract]. J Allergy Clin Immunol 1999 Jan; 103 Pt 2: S132

    Google Scholar 

  14. Wolthers OD, Pedersen S. Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate. Arch Dis Child 1993 May; 68(5): 673–6

    Article  PubMed  CAS  Google Scholar 

  15. MacKenzie C. Effects of inhaled corticosteroids on growth. J Allergy Clin Immunol 1998 Apr; 101 (4 Pt 2): S451–5

    Article  PubMed  CAS  Google Scholar 

  16. Ferguson AC, Spier S, Manjra A, et al. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. J Pediatr 1999 Apr; 422–7

    Google Scholar 

  17. Li JTC, Goldstein MF, Gross GN, et al. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol 1999 Apr; 103(4): 622–9

    Article  PubMed  CAS  Google Scholar 

  18. Baker J, Yunginger J, Walton-Bowen K, et al. A safety and HPA-axis evaluation of four dose regimens of budesonide nebulizing suspension (BNS; pulmicort® respules™) compared with placebo (PBO) in infants and young children with persistent asthma [abstract]. Am J Respir Crit Care Med 1998; 157: A405

    Google Scholar 

  19. Irani AA, Nayak A, Cruz-Rivera M, et al. HPA-axis function in infants and young children with persistent asthma treated for 52 weeks with budesonide inhalation suspension (BIS; pulmicort respules™) [abstract]. J Allergy Clin Immunol 1999 Jan; 103 Pt 2: S130–1

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Do inhaled corticosteroids stunt the growth of children?. Drugs Ther. Perspect 14, 12–14 (1999). https://doi.org/10.2165/00042310-199914030-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199914030-00004

Keywords

Search

Navigation